New oral antiviral drug to be used for treatment of COVID-19
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Teachers' Day: What does 'teacher' mean to people?
- Cooking in high-altitude Xizang brings unique pressures
- Picnic camp sites boost incomes in Dagtse, Lhasa
- Chinese singer apologizes for giving wrong number at concert
- China adds 744 drugs to reimbursement list
- Chinese, US theater commanders hold video call